Outdoor light linked with teensﾒ sleep and mental health
On Jul. 8, 2020, research showed that adolescents who live in areas that have high levels of artificial…
Kleo Pharmaceuticals announced $5 million grant to advance development of COVID-19 hyperimmune globulin mimic as therapeutic for infected patients
On Jul. 8, 2020, Kleo Pharmaceuticals announced that it had received a $5 million grant from the Bill…
NanoViricides reported safety and tolerability of anti-Coronavirus drug candidates observed in animal model
On Jul. 8, 2020, NanoViricides announced that excellent safety and tolerability of the drug candidates it is developing…
HPV test missed twice as many women who develop cervical cancer as cotesting
On Jul. 8, 2020, a Health Trendsﾙ study from researchers at Quest Diagnostics and the University of Pittsburgh…
USDA announced an initial purchase of vaccine for National Animal Vaccine and Veterinary Countermeasures Bank
On Jul. 8, 2020, the USDA announced the initial purchase of vaccine for the National Animal Vaccine and…
Long-acting injectable form of HIV prevention outperformed daily pill in NIH study
On Jul. 7, 2020, a pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form of the HIV drug…
The FDA reported false positive results with BD SARS-CoV-2 reagents for the BD Max System
On Jul. 7, 2020, the FDA alerted clinical laboratory staff and health care providers of an increased risk…
National UK study investigated long-term health impacts of COVID-19
On Jul. 7, 2020, a major UK research study – PHOSP-COVID, will investigate the long-term health impacts of…
The FDA reported false positive results with BD SARS-CoV-2 reagents for the BD Max System
On Jul. 7, 2020, the FDA alerted clinical laboratory staff and health care providers of an increased risk…
Oxford COVID-19 study reported face masks work, call for immediate adoption
On Jul. 7, 2020, Oxfordﾒs Leverhulme Centre for Demographic Science reported that cloth face coverings, even homemade masks…
GSK and Medicago announced collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
On Jul. 7, 2020, GlaxoSmithKline and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine…
Philips introduced first-of-a-kind mobile ICUs in India to tackle COVID-19 and other emergencies
On Jul. 7, 2020, Royal Philips announced it had introduced first-of-its-kind mobile Intensive Care Units (ICUs) in India….
Cerus reported successful inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma
On Jul. 7, 2020, Cerus announced study results that demonstrated the INTERCEPT Blood System inactivates SARS-CoV-2, the causative…
In vitro testing of Innovation Pharmasﾒ Brilacidin for COVID-19 showed consistent anti-SARS-CoV-2 efficacy
On Jul. 7, 2020, Innovation Pharma reported the latest developments related to research into Brilacidin as a potential…
LabCorp lanuched first digital COVID-19 service that improves the doctor and patient experience
On Jul. 7, 2020, LabCorpﾮ launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital…
Tonix Pharma announced plans for Massachusetts R&D facility to accelerate clinical development of vaccines and protein-based therapeutics
On Jul. 7, 2020, Tonix Pharmaceuticals announced its intent to purchase an approximately 40,000 square foot facility in…
Merck announced analyses showing additional safety and efficacy data for investigational Islatravir in combination with Doravirine in adults with HIV-1 infection
On Jul. 6, 2020, Merck announced a new analyses from the Phase 2b trial evaluating the safety and…
The FDA issued an emergency use authorization for the third diagnostic test for detection and differentiation of the viruses that cause flu and COVID-19
On Jul. 6, 2020, the FDA issued an emergency use authorization (EUA) for the third diagnostic test for…
Ignoring airborne COVID spread risky
On Jul. 6, 2020, the lack of universal recognition that COVID-19 is transmitted via airborne particles, along with…
Sinovac COVID-19 vaccine collaboration with Butantan received approval from Brazilian regulator for phase III trial
On Jul. 6, 2020, Sinovac Biotech announced that on Jul. 3, 2020, the Brazilian National Regulatory Agency, Anvisa,…
Immune Regulation partnered with DynPort Vaccine to advance drug product for COVID-19 into clinical trials
On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…
Emergent BioSolutions signed five-year agreement for large-scale drug substance manufacturing for Johnson & Johnsonﾒs COVID-19 vaccine candidate
On Jul. 6, 2020, Emergent BioSolutions announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, a Johnson &…
AIM ImmunoTech signed material transfer and research agreement with Japan’s National Institute of Infectious Diseases and Shionogi & Co to test Ampligen as potential vaccine adjuvant for COVID-19
On Jul. 6, 2020, AIM ImmunoTech announced that it had signed a material transfer and research agreement with…
ADMA Biologics opened its newest ADMA BioCenters plasma collection facility
On Jul. 6, 2020, ADMA Biologics announced the commencement of operations and initiation of collections at its newest…
Regeneron announced start of REGN-COV2 phase 3 COVID-19 prevention trial in collaboration with National Institute of Allergy and Infectious Diseases
On Jul. 6, 2020, Regeneron announced initiation of late-stage clinical trials evaluating REGN-COV2, Regeneron’s investigational double antibody cocktail…
Mylan secured regulatory approval for remdesivir lyophilized powder for injection 100 mg/vial in India for restricted emergency use in COVID-19 patients
On Jul. 6, 2020, Mylan announced that the Drug Controller General of India (DCGI) has approved its remdesivir…
EC granted conditional Marketing Authorization for Gileadﾒs Vekluryﾮ (remdesivir) for treatment of COVID-19
On Jul. 3, 2020, Gilead Sciences announced the European Commission had granted conditional marketing authorization for Vekluryﾮ (remdesivir)…
Abivax treated first patient in phase 2b/3 ABX464 Covid-19 clinical trial
On Jul. 2, 2020, Abivax announced that the first patient has been treated in its Phase 2b/3 study…
TGen teamed with Poba Medical to produce 10,000 COVID-19 test kits per month
On Jul. 2, 2020, in response to the continuing need for more COVID-19 diagnostic tests, the Translational Genomics…
Maxim Biomedical rapid antigen COVID-19 test to deliver results in less than 15 minutes
On Jul. 2, 2020, Maxim Biomedical announced plans to produce and market as many as 3 million Maxim…